Status:
COMPLETED
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study
Lead Sponsor:
University Hospital Erlangen
Conditions:
Hepatocellular Carcinoma
Cholangiocarcinoma, Intrahepatic
Eligibility:
All Genders
18+ years
Brief Summary
Aim of this prospective national multicenter study is to improve standardization of contrast-enhanced ultrasound (CEUS) in the non-invasive diagnosis of hepatocellular carcinoma (HCC) in high-risk pat...
Detailed Description
To date, CEUS criteria for non-invasive diagnosis of HCC include arterial phase hyperenhancement, followed by contrast washout in the portal venous or late phase. We would like to investigate the foll...
Eligibility Criteria
Inclusion
- high risk for HCC
- focal liver lesion on B-mode ultrasound
Exclusion
- pre-treated HCC lesion
- systemic therapy for HCC (sorafenib, regorafenib and others)
Key Trial Info
Start Date :
April 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 6 2019
Estimated Enrollment :
517 Patients enrolled
Trial Details
Trial ID
NCT03405909
Start Date
April 21 2018
End Date
April 6 2019
Last Update
March 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Erlangen, Department of Medicine 1
Erlangen, Bavaria, Germany, 91054